Savitr Capital is a private equity firm in San Francisco that focuses on investing in renewable and clean energy companies. Founded in San Francisco, California, United States, it invests in early stage ventures, series B, venture rounds, and series C rounds. Its portfolio companies include OncoCell MDx, Ancora Heart, and Naurex. As of June 2020, Savitr Capital has made four investments. Their most recent investment was on September 11, 2019, when OncoCell MDx raised $22.2M. Savitr Capital has had one exit, which was Naurex. The company’s goal is to provide risk adjusted returns by investing in companies in the clean and renewable energy sectors.
Savitr Capital is actively using 16 technologies for its website. These include Viewport Meta, IPhone / Mobile Compatible, and SSL by Default.
A company focused on developing therapeutics for the treatment of depression and other central nervous system disorders
OncoCell MDx is a Royal Oak, Michigan-based medical diagnostics company developing an immunogenomic liquid biopsy platform for the early detection of cancer.
Founder & Managing Member
Ian Ferrier Ph.D
Executive, Fund Operations & Accounting
Documentaries, videos and podcasts